ICBC CREDIT SUISSE

An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.

159217 trades at 1.112 CNY today, its price has risen 0.09% in the past 24 hours. Track more dynamics on 159217 price chart.

159217 net asset value is 1.12 today — it's risen 9.80% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.

159217 assets under management is ‪4.12 B‬ CNY. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.

Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.

No, 159217 doesn't pay dividends to its holders.

159217 trades at a premium (0.31%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.

159217 shares are issued by ICBC Credit Suisse Asset Management Co., Ltd.

159217 follows the China Securities Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

The fund started trading on Mar 26, 2025.